MedPath
TGA Approval

CEFTAZIDIME KABI ceftazidime (as pentahydrate) 2 g powder for injection vial (223569)

223569

CEFTAZIDIME KABI ceftazidime (as pentahydrate) 2 g powder for injection vial

Fresenius Kabi Australia Pty Ltd

July 2, 2015

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/4bfa2a067ad6f8a28cb3798b9986c2ee.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/1bdc9c2eb861e10c65e87436a33f46ad.pdf

Active Ingredients

ceftazidime pentahydrate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

CEFTAZIDIME KABI ceftazidime (as pentahydrate) 2 g powder for injection vial (223569) - TGA 批准文号 | MedPath